Punishing health care fraud--is the GSK settlement sufficient?

N Engl J Med. 2012 Sep 20;367(12):1082-5. doi: 10.1056/NEJMp1209249. Epub 2012 Sep 12.
No abstract available

MeSH terms

  • Compensation and Redress / legislation & jurisprudence*
  • Drug Industry / ethics
  • Drug Industry / legislation & jurisprudence*
  • Drug Industry / organization & administration
  • Drug Labeling / legislation & jurisprudence*
  • Federal Government
  • Fraud / legislation & jurisprudence*
  • Government Regulation
  • Marketing / ethics
  • Marketing / legislation & jurisprudence
  • Organizational Culture
  • United States
  • Whistleblowing